bioRxivNeurosciencePreprint
Changes in Tissue Protein N-Glycosylation and Associated Molecular Signature Occur in the Human Parkinsonian Brain in a Region-Specific Manner
Ana Lúcia RebeloiD, Richard R. DrakeiD, Martina Marchetti‐DeschmanniD, Radka SaldovaiD, Abhay S. PanditiD
Abstract
Parkinsons Disease (PD) associated state of neuroinflammation due to the aggregation of aberrant proteins is widely reported. One type of post-translational modification involved in protein stability is glycosylation. Here, we aimed to characterise the human Parkinsonian nigro-striatal N-glycome, and related transcriptome/proteome, and its correlation with endoplasmic reticulum stress and unfolded protein response (UPR), providing a comprehensive characterisation of the PD molecular signature. Significant changes were seen upon PD: 3% increase in sialylation and 5% increase in fucosylation in both regions, and 2% increase in oligomannosylated N-glycans in the substantia nigra. In the latter, a decrease in the mRNA expression of sialidases and an upregulation in the UPR pathway were also seen. To show the correlation between these, we also describe an in vitro functional study where changes in specific glycosylation trait enzymes (inhibition of sialyltransferases) led to impairments in cell mitochondrial activity, changes in glyco-profile and upregulation in UPR pathways. This complete characterisation of the human nigro-striatal N-glycome provides an insight into the glycomic profile of PD through a transversal approach while combining the other PD "omics" pieces, which can potentially assist in the development of glyco-focused therapeutics.
- Citations
- 2
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Single nuclear RNA sequencing shows altered microglial and astrocytic functions in post-mortem Parkinson's disease tissue
Indra Roy, Michael Fiorini, … Thomas M. Durcan·BMC Genomic DataPeer-reviewed·Jul 4, 2026
- A novel post-translational proteomics platform identifies neurite outgrowth impairments in Parkinson's disease GBA-N370S dopamine neurons
Helle Bogetofte, Brent James Ryan, … Richard Wade‐Martins·Cell ReportsPeer-reviewed·Mar 1, 2023
- Oligodendroglia vulnerability in the human dorsal striatum in Parkinson's disease
Juan M. Barba-Reyes, Lisbeth Harder, … Ana B. Muñoz‐Manchado·Acta NeuropathologicaPeer-reviewed·May 5, 2025
- Glycation of alpha-synuclein enhances aggregation and neuroinflammatory responses
Eftychia Vasili, Annekatrin König, … Tiago F. Outeiro·npj Parkinson s DiseasePeer-reviewed·Oct 23, 2025
- Glycated alpha-synuclein assemblies cause distinct Parkinsons disease pathogenesis in mice
Akshaya Rajan, Anish Varghese, … Poonam Singh Thakur·ACS Chemical NeurosciencePeer-reviewed·Sep 12, 2025
- Correcting differential gene expression analysis for cyto-architectural alterations in substantia nigra of Parkinson's disease patients reveals known and potential novel disease-associated genes and pathways
Federico Ferraro, Christina Fevga, … Marcel J. T. Reinders·CellsPeer-reviewed·Jan 7, 2022